Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
South African Press Association - February 18, 2004
This bulk of this will go towards the cost of the provincially-administered antiretroviral treatment programmes.
The additional spending will bring total spending on Aids by the provinces and national government to R12,4-billion over the three years of the medium-term expenditure framework (MTEF).
The plan for a roll-out of ARV treatment at public facilities was approved by cabinet last year, and though the Western Cape already has even more sites than the plan requires, other provinces are lagging behind.
Last year, the MTEF figure for the 2004/05 conditional grant to provinces for programmes - including mother-to-child transmission prevention, post-exposure prophylaxis and voluntary counselling and testing - was R482-million.
However, the new budget allocates provinces an additional R300-million, most of it for ARV treatment.
Next year (2005/06) the figure will be boosted from R535-million to R1,2-billion, and in 2006/07 from R567-million to R1,6-billion, in addition to a total of R172-million extra for the national department.
According to the Treasury, the bulk of the R12,4-billion in HIV/Aids spending over the coming three years will be made up of R6,9-billion in adjustments to provinces' equitable shares to boost general health spending in the face of the costs of Aids.
The rest includes R3,5-billion in conditional grants specifically directed at HIV/Aids, including the R2,1-billion for ARV treatment, R1,3-billion for the national department of health's condoms and prevention programmes, R410-million in education grants for life skills, and R223-million to be channelled through the social development conditional grants for home-based care and support.
About 5,3 million South Africans in a population of 44,8 million are infected with HIV or Aids, a higher rate than any other country.
040218
SA040206
Copyright © 2004 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .